Prostate Cancer - Results from #260

Impact of [177Lu]Lu-PSMA-617 Radioligand Therapy on Reference Organ Uptake Assessed by [68Ga]Ga-PSMA-11-PET/CT. August 14, 2023

STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathway. August 14, 2023

Improved Prostate-Specific Membrane Antigen (PSMA) Stimulation Using a Super Additive Effect of Dutasteride and Lovastatin In Vitro. August 14, 2023

A novel MRI/ultrasound fusion prostate biopsy technique using transperineal ultrasound: An initial experience. August 14, 2023

Racial Disparities in Prostate Cancer Screening: The Role of Shared Decision-Making. August 14, 2023

Copy number architectures define treatment-mediated selection of lethal prostate cancer clones. August 14, 2023

Severe hypercalcaemia in metastatic prostate cancer with biallelic BRCA2 mutations and lytic bone lesions. August 14, 2023

Discrete-Choice Experiment to Understand the Preferences of Patients with Hormone-Sensitive Prostate Cancer in the USA, Canada, and the UK. August 14, 2023

How to Report PSMA PET. August 11, 2023

Identification of a Predictive Genomic Biomarker for Prostate-directed Therapy in Synchronous Low-volume Metastatic Castration-sensitive Prostate Cancer. August 11, 2023

Profile of Relugolix in the Management of Advanced Hormone-Sensitive Prostate Cancer: Design, Development, and Place in Therapy. August 11, 2023

Third generation quinoline-3-carboxamide transcriptional disrupter of HDAC4, HIF-1α, and MEF-2 signaling for metastatic castration-resistant prostate cancer. August 11, 2023

Addition of Cribriform and Intraductal Carcinoma Presence to Prostate Biopsy Reporting Strengthens Pretreatment Risk Stratification Using CAPRA and NCCN Tools. August 11, 2023

Reliable Visualization of the Treatment Effect of Transperineal Focal Laser Ablation in Prostate Cancer Patients by Magnetic Resonance Imaging and Contrast-enhanced Ultrasound Imaging. August 10, 2023

Radiation Facility Volume and Survival for Men With Very High-Risk Prostate Cancer Treated with Radiation and Androgen Deprivation Therapy. August 10, 2023

Disparities in time to prostate cancer treatment initiation before and after the Affordable Care Act. August 10, 2023

Impact of Peritoneal Interposition Flap on Patients Undergoing Robot-assisted Radical Prostatectomy and Pelvic Lymph Node Dissection: A Systematic Review and Meta-analysis of Randomized Controlled Trials. August 10, 2023

Diagnostic performance of 18F-labeled PSMA PET/CT in patients with biochemical recurrence of prostate cancer: a systematic review and meta-analysis. August 10, 2023

Loss of SYNCRIP unleashes APOBEC-driven mutagenesis, tumor heterogeneity, and AR-targeted therapy resistance in prostate cancer. August 10, 2023

BRCA-deficient metastatic prostate cancer has an adverse prognosis and distinct genomic phenotype. August 9, 2023

Page 14 of 1335